Progressive supranuclear palsy is a devastating neurological disorder without treatment. Here, the authors leveraged omics data and model organisms to nominate, prioritize, and validate high-confidence candidate genes as therapeutic targets.
- Yuhao Min
- Xue Wang
- Nilüfer Ertekin-Taner
